1. Balch CM, Riley LB, Bae Y-J, Salmeron MA, Platsoucas CD, von Eschenbach AC, Itoh K (1990) Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg 125:200–205.
2. Alexander J, Rayman P, Edinger M, Connelly R, Tubbs R, Bukowski R, Pontes E, Finke J (1990) TIL from renal cell carcinoma: restimulation with tumor influences proliferation and cytotoxic activity. Int J Cancer 45:119–124.
3. Belldegrun A, Muul LM, Rosenberg SA (1988) Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell carcinoma: Isolation, characterization, and antitumor activity. Cancer Res 47: 206–214.
4. Finke JH, Rayman P, Alexander J, Edinger M, Tubbs RR, Connelly R, Pontes E, Bukowski R (1990) Characterization of the cytotoxic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma. Cancer Res 50:2363–2370.
5. Hayakawa K, Salmeron MA, Parkinson DR, Markowitz AB, von Eschenbach AC, Legha SS, Balch CM, Ross MI, Augustus LB, Itoh K (1991) Study of tumor-infiltrating lymphocytes for adoptive therapy of renal cell carcinoma (RCC) and metastatic melanoma. Journal of Immunology 10: 313–325.